Daniele Cattaneo
University of Milan(IT)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(IT)Ospedale Maggiore(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis(2019)145 cited
- → A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis(2022)111 cited
- → Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission(2018)105 cited
- → A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia(2020)101 cited
- → Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients(2016)98 cited
- → High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists(2016)89 cited